Tenet Healthcare Corp (FRA:THC1) Stock Price, Trades & News

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	0.16
Equity-to-Asset	0.15
Debt-to-Equity	2.84
Debt-to-EBITDA	2.38
Interest Coverage	5.39
Piotroski F-Score	8/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.16	Distress Grey Safe
Beneish M-Score	-2.57	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

6/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	10.6
	3-Year EBITDA Growth Rate	21
	3-Year EPS without NRI Growth Rate	35.1
	3-Year FCF Growth Rate	112.4
	3-Year Book Growth Rate	63.2
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	8.78
	Future 3-5Y Total Revenue Growth Rate Estimate	3.21

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	75.34
	9-Day RSI	75.58
	14-Day RSI	73.68
	3-1 Month Momentum %	6.54
	6-1 Month Momentum %	3.82
	12-1 Month Momentum %	16.43

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.41
	Quick Ratio	1.35
	Cash Ratio	0.39
	Days Inventory	32.18
	Days Sales Outstanding	41.37
	Days Payable	127.48

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	5.3
	Shareholder Yield %	7.53

Profitability Rank

7/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	82.83
	Operating Margin %	19.52
	Net Margin %	9.9
	EBITDA Margin %	24.64
	FCF Margin %	13.36
	OCF Margin %	17.73
	ROE %	52.23
	ROA %	7.49
	ROIC %	14.08
	3-Year ROIIC %	144.08
	ROC (Joel Greenblatt) %	73.04
	ROCE %	18.79
	Years of Profitability over Past 10-Year	7
	Moat Score	6
	Tariff Resilience Score	8

GF Value Rank

5/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	9.83
	Forward PE Ratio	12.56
	PE Ratio without NRI	13.17
	Shiller PE Ratio	31.13
	Price-to-Owner-Earnings	9.58
	PEG Ratio	0.7
	PS Ratio	0.98
	PB Ratio	4.4
	Price-to-Free-Cash-Flow	7.36
	Price-to-Operating-Cash-Flow	5.54
	EV-to-EBIT	7.61
	EV-to-Forward-EBIT	5.46
	EV-to-EBITDA	6.39
	EV-to-Forward-EBITDA	4.74
	EV-to-Revenue	1.57
	EV-to-Forward-Revenue	1.36
	EV-to-FCF	11.79
	Price-to-GF-Value	1.39
	Price-to-Projected-FCF	0.7
	Price-to-Median-PS-Value	3.21
	Price-to-Peter-Lynch-Fair-Value	0.75
	Earnings Yield (Greenblatt) %	13.14
	FCF Yield %	14.74
	Forward Rate of Return (Yacktman) %	23.89

Financials (Next Earnings Date:2026-10-28 Est.)

Annual Quarterly TTM

FRA:THC1's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Tenet Healthcare Corp Operating Data

Annual Quarterly

FRA:THC1's Complete Operating Data

No operating data available for Tenet Healthcare Corp.

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Tenet Healthcare Corp Executives

Details

GF Value™: €158.32

FRA:THC1

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 5 Medium warning signs with THC1. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	19,470.439
	EPS (TTM) (€)	22.363
	Beta	0.9936
	3-Year Sharpe Ratio	0.76
	3-Year Sortino Ratio	1.38
	Volatility %	43.08
	14-Day RSI	73.68
	14-Day ATR (€)	5.861843
	20-Day SMA (€)	184.95
	12-1 Month Momentum %	16.43
	52-Week Range (€)	135 - 228
	Shares Outstanding (Mil)	80.52

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	8
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Tenet Healthcare Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Tenet Healthcare Corp Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-10-28 10:30	In 89 days
Third quarter earnings results for 2026	2026-10-28	In 88 days
Second quarter earnings conference call for 2026	2026-07-24 10:30	169.00 (+0.00%)
Second quarter earnings results for 2026	2026-07-24	169.00 (+0.00%)
General meeting for 2026	2026-05-27 09:00	150.00 (+0.00%)
Guidance call for 2026	2026-05-13 18:00	162.00 (+0.00%)
First quarter earnings conference call for 2026	2026-04-30 10:00	152.00 (+0.00%)
First quarter earnings results for 2026	2026-04-30	152.00 (+0.00%)
Barclays 28th Annual Global Healthcare Conference	2026-03-10 09:30	200.00 (+0.00%)
Annual report for 2025	2026-02-17	195.00 (+0.00%)

Show

Entries

Tenet Healthcare Corp Frequently Asked Questions

What is Tenet Healthcare Corp(FRA:THC1)'s stock price today?

The current price of FRA:THC1 is €220.00. The 52 week high of FRA:THC1 is €228.00 and 52 week low is €135.00.

When is next earnings date of Tenet Healthcare Corp(FRA:THC1)?

The next earnings date of Tenet Healthcare Corp(FRA:THC1) is 2026-10-28 Est..

Does Tenet Healthcare Corp(FRA:THC1) pay dividends? If so, how much?

Tenet Healthcare Corp(FRA:THC1) does not pay dividend.

Press Release

	Subject	Date
	Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook	2026-07-23
	Tenet to Report Its Second Quarter 2026 Results on July 24	2026-06-22
	Tenet Reports Strong First Quarter 2026 Results	2026-04-30
	Tenet to Report its First Quarter 2026 Results on April 30th	2026-03-31
	Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference	2026-03-04
	Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook	2026-02-11
	Tenet Announces Accretive Transaction and Previews Strong 2025 Results	2026-02-02
	Tenet to Report its Fourth Quarter 2025 Results on February 11th	2026-01-07
	Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes	2025-11-03
	Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes	2025-11-03

10/Page

Articles on Tenet Healthcare Corp

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.